A Study of LY3549492 in Chinese Participants With Type 2 Diabetes Mellitus

Phase 1 Completed 36 enrolled Eli Lilly and Company

RandomizedParallel-groupDouble-blindBasic science

Summary

The main purpose of this study is to investigate LY3549492 in Chinese participants with type 2 diabetes. Participation in the study will last about 18 weeks.

Timeline

Start: 2025-07-25
Primary completion: 2026-01-27
Completion: 2026-01-27

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	LY3549492	Unknown	—	Oral

A Study of LY3549492 in Chinese Participants With Type 2 Diabetes Mellitus

Summary

Timeline

Drugs

Indications